Vertex to Present at the RBC Global Healthcare Conference on February 25 2014 RBC Capital Markets' Global Healthcare Conference Business Wire BOSTON -- February 20, 2014 Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it will be presenting at the 2014 RBC Capital Markets Global Healthcare Conference on Tuesday, February 25 at 1:35 p.m. ET. The audio portion of the remarks will be accessible live through Vertex’s website at www.vrtx.com in the “Investors” section under the “Events and Presentations” link. To ensure a timely connection, it is recommended that users register at least 15 minutes prior to the scheduled webcast. A replay of the webcast will also be archived on the company’s website for a period of two weeks following the presentation. About Vertex Vertex is a global biotechnology company that aims to discover, develop and commercialize innovative medicines so people with serious diseases can lead better lives. Vertex scientists and our collaborators are working on new medicines to cure or significantly advance the treatment of cystic fibrosis, hepatitis C, rheumatoid arthritis and other life-threatening diseases. In addition to our clinical development programs, Vertex has more than a dozen ongoing preclinical programs aimed at other serious and life-threatening diseases. Founded in 1989 in Cambridge, Mass., Vertex today has research and development sites and commercial offices in the United States, Europe, Canada and Australia. For four years in a row, Science magazine has named Vertex one of its Top Employers in the life sciences. For additional information and the latest updates from the company, please visit www.vrtx.com. (VRTX-WEB) Contact: Vertex Pharmaceuticals Incorporated Investors: Michael Partridge, 617-341-6108 or Kelly Lewis, 617-961-7530
Vertex to Present at the RBC Global Healthcare Conference on February 25
Press spacebar to pause and continue. Press esc to stop.